ARVINAS, INC.
ARVN
31 insider filings · Latest: Jun 24, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | Feb 25 10:09 PM | David K LoomisChief Accounting Officer | Sale | 1,108 | $12.16 | $13.5K | 29,692(D) | View → |
| Feb 23, 2026 | Feb 25 10:09 PM | Angela M CacaceChief Scientific Officer | Sale | 3,609 | $12.16 | $43.9K | 147,623(D) | View → |
| Feb 23, 2026 | Feb 25 10:08 PM | Randy TeelDirector, President and CEO | Sale | 4,786 | $12.16 | $58.2K | 149,696(D) | View → |
| Feb 23, 2026 | Feb 23 10:55 PM | Angela Cacace | Proposed Sale | 3,609 | $12.16 | $43.9K | — | View → |
| Feb 23, 2026 | Feb 23 10:55 PM | Randy Teel | Proposed Sale | 4,786 | $12.16 | $58.2K | — | View → |
| Feb 13, 2026 | Feb 18 11:16 PM | Randy TeelDirector, President and CEO | Sale | 4,403 | $11.89 | $52.4K | 154,482(D) | View → |
| Feb 13, 2026 | Feb 18 11:14 PM | Andrew SaikChief Financial Officer | Sale | 5,134 | $11.89 | $61.0K | 159,267(D) | View → |
| Feb 13, 2026 | Feb 18 11:13 PM | Angela M CacaceChief Scientific Officer | Sale | 4,592 | $11.89 | $54.6K | 151,232(D) | View → |
| Feb 13, 2026 | Feb 18 11:12 PM | Berkowitz NoahChief Medical Officer | Sale | 5,685 | $11.89 | $67.6K | 163,938(D) | View → |
| Feb 13, 2026 | Feb 18 11:11 PM | David K LoomisChief Accounting Officer | Sale | 1,016 | $11.89 | $12.1K | 30,800(D) | View → |
| Feb 13, 2026 | Feb 13 10:00 PM | Noah Berkowitz | Proposed Sale | 5,685 | $11.89 | $67.6K | — | View → |
| Feb 13, 2026 | Feb 13 10:00 PM | Angela Cacace | Proposed Sale | 4,592 | $11.89 | $54.6K | — | View → |
| Feb 13, 2026 | Feb 13 9:59 PM | Randy Teel | Proposed Sale | 4,403 | $11.89 | $52.4K | — | View → |
| Feb 13, 2026 | Feb 13 9:58 PM | Andrew Saik | Proposed Sale | 5,134 | $11.89 | $61.1K | — | View → |
| Jun 24, 2025 | Jun 23 8:13 PM | Andrew Saik | Proposed Sale | 5,927 | $7.35 | $43.6K | — | View → |
| Mar 18, 2025 | Mar 19 1:50 AM | Noah Berkowitz | Proposed Sale | 8,658 | $8.59 | $74.4K | — | View → |
| Feb 24, 2025 | Feb 25 1:50 AM | Ian Taylor | Proposed Sale | 9,020 | $16.71 | $150.7K | — | View → |
| Feb 24, 2025 | Feb 25 1:48 AM | John G Houston | Proposed Sale | 31,338 | $16.71 | $523.8K | — | View → |
| Feb 24, 2025 | Feb 25 1:46 AM | Angela M Cacace | Proposed Sale | 4,207 | $16.69 | $70.2K | — | View → |
← Previous
Page 2 of 2
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | Jun 26 8:23 PM | Alsup Laurie SmaldoneDirector | Grant/Award | 22,714 | $8.05 | 22,714(D) | View → |
| Jun 24, 2026 | Jun 26 8:23 PM | Leslie V NorwalkDirector | Grant/Award | 22,714 | $8.05 | 22,714(D) | View → |
| Jun 24, 2026 | Jun 26 8:22 PM | Briggs MorrisonDirector | Grant/Award | 22,714 | $8.05 | 22,714(D) | View → |
| Jun 24, 2026 | Jun 26 8:22 PM | Edward Moore Kennedy Jr.Director | Grant/Award | 22,714 | $8.05 | 22,714(D) | View → |
| Jun 24, 2026 | Jun 26 8:21 PM | Everett CunninghamDirector | Grant/Award | 22,714 | $8.05 | 22,714(D) | View → |
| Jun 24, 2026 | Jun 26 8:21 PM | Linda BainDirector | Grant/Award | 22,714 | $8.05 | 22,714(D) | View → |
| Feb 26, 2026 | Mar 3 2:01 AM | David K LoomisVP, Chief Accounting Officer | Grant/Award | 18,504 | $13.38 | 18,504(D) | View → |
| Feb 26, 2026 | Mar 3 2:00 AM | Angela M CacaceChief Scientific Officer | Grant/Award | 67,000 | $13.38 | 67,000(D) | View → |
| Feb 26, 2026 | Mar 3 1:59 AM | Berkowitz NoahChief Medical Officer | Grant/Award | 67,000 | $13.38 | 67,000(D) | View → |
| Feb 26, 2026 | Mar 3 1:58 AM | Andrew SaikChief Financial Officer | Grant/Award | 67,000 | $13.38 | 67,000(D) | View → |
| Feb 26, 2026 | Mar 3 1:58 AM | Randy TeelDirector, President and CEO | Grant/Award | 218,691 | $13.38 | 218,691(D) | View → |